10:31 a.m. ET -- Biogen Inc. and Eisai Co. are two of the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The U.S. Food and Drug Administration on Friday granted conditional approval to the companies' lecanemab, the most promising drug to date in a new class of medicines that may help slow cognitive decline caused by Alzheimer's disease. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com).

(END) Dow Jones Newswires

January 09, 2023 10:46 ET (15:46 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Eisai (PK) (USOTC:ESALY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Eisai (PK) 차트를 더 보려면 여기를 클릭.
Eisai (PK) (USOTC:ESALY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Eisai (PK) 차트를 더 보려면 여기를 클릭.